Clinical Trials
- Liver Cancer
A Phase Ib/II, Open-Label, Multicenter, Randomized Platform Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma (MORPHEUS-NEO HCC)
- Colorectal Cancer, Liver Cancer, Pancreatic Cancer
An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Multiple Solid Tumors
- Liver Cancer
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
- Gynecological Cancers, Liver Cancer, Lung Cancer
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Patients With Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Melanoma or Endometrial Carcinoma
- Bladder Cancer, Brain and Other Nervous System Cancers, Colorectal Cancer, Gynecological Cancers, Kidney Cancer, Liver Cancer, Lung Cancer, Other Cancers, Pediatric Cancers, Sarcoma Cancers, Thyroid and Other Endocrine Cancers
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study